Your Navigation:PCAR > Abstract
Search pcar
检索项:
检索词:
Abstract
Pharmaceutical Care and Research: 2019; 19(1):36-40
DOI: 10.5428/pcar20190110
Clinical pharmacist involvement in pharmaceutical care of anti-infective treatment with vancomycin
1. SUN Zhonghui1(1.Department of Pharmacy,No.5 Hospital of Xi’an,Xi’an 710082,China sun_zhonghui@163.com)
2. YAO Hongping2(2.Department of Pharmacy,First Hospital Affiliated to Xi’an Jiaotong University,Xi’an 710061,China )
3. SUN Li3(3.Northwestern Polytechnical University,Xi’an 710072,China li_ly_sunshine@163.com)
ABSTRACT  Objective: To explore pharmaceutical care of the patients treated with vancomycin by clinical pharmacists.Methods: In the light of typical cases,clinical pharmacists provided recommendations for patient treatment profile with vancomycin,as well as pharmaceutical care in the management of such adverse drug reactions (ADRs) as red man syndrome,drug fever and agranulocytosis and so on.Results:Pharmaceutical care offered by clinical pharmacists enhanced the safety and efficacy of drug therapy.Conclusion:With active involvement in drug therapy scheme,management of ADRs and perfect pharmaceutical care as entry points,clinical pharmacists could play a positive role in pharmaceutical care of the patients treated with vanocomycin.
Welcome to PCAR! You are the number 389 reader of this article!
Please cite this article as:
SUN Zhonghui1,YAO Hongping2,SUN Li3,. Clinical pharmacist involvement in pharmaceutical care of anti-infective treatment with vancomycin[J]. Pharmaceutical Care and Research / yao xue fu wu yu yan jiu. 2019; 19(1): 36-40.
References:
1. CHINET China Bacterial Resistance Monitoring Network,Institute of Antibiotics,Huashan Hospital Affiliated to Fudan University.CHINET surveillance results of bacterial resistance in China(2017)[EB/OL].(2018-01-23)[2018-02-10].http://www.sific.com.cn/InsidePage/1000/67/7970.html.In Chinese.
2. ZHAI Suodi,HE Bei,WANG Rui,et al.Interpretation of Guidelines for the therapeutic drug monitoring of vancomycin in China[J].Chin J Clin Pharmacol,2016,32(17):1633-1636.In Chinese with English abstract.
3. GUO Xuesong,XIAO Feng.Analysis of vancomycin plasma level and adverse drug reactions in neonates[J].Chin J Pharmacovigil,2016,13(7):414-416.In Chinese with English abstract.
4. FANG Jie,LIU Liyan,HUANG Jie,et al.Study on the optimization of dosage regimen of vancomycin[J].Pharm Care Res,2017,17(3):179-182.In Chinese with English abstract.
5. Renz C,Lynch J,Thurn J,et al.Histamine release during rapid vancomycin administration[J].Inflamm Res,1998,47(Suppl 1):S69-S70.
6. LIU Bo,ZHOU Xingzhuo,ZHAO Liyan,et al.Analysis of 1 case of drug fever induced by cefoperazone sulbactam by clinical pharmacists[J].China Pharmaceuticals,2017,26(21):88-91.In Chinese with English abstract.
7. Hung Y P,Lee N Y,Chang C M,et al.Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever,rash,or neutropenia:a retrospective chart review[J].Clin Ther,2009,31(9):1977-1986.
8. WANG Fu,ZHANG Yingyuan.Practical anti-infectious drug therapy[M].2nd ed.Beijing: People’s Health Press,2012:592-593.In Chinese.
9. JI Huanhuan,LUO Jian,SONG Lin,et al.Analysis of vancomycin-induced neutropenia adverse reactions/adverse events in children[J].China Pharmacy,2016,27(6):760-762.In Chinese with English abstract.
10. Black E,Lau T T Y,Ensom M H H.Vancomycin-induced neutropenia:is it dose-or duration-related?[J].Ann Pharmacother,2011,45(5):629-638.
11. Pai M P,Mercier R C,Koster S A.Epidemiology of vancomycin-induced neutropenia in patients receiving home intravenous infusion therapy[J].Ann Pharmacother,2006,40(2):224-228.
《药学服务与研究》杂志社 All Rights Reserved 网站备案号:鲁B2-20061008
·地址:上海市杨浦区长海路168号18号楼东三楼 邮政编码:200433
·联系电话(传真):86-21-65519829, 021-31162330
·电子邮件:PharmCR@vip.163.com
·技术支持:中国康网
管理员入口